ArticleaBIOTECH2020
Single-nucleotide editing for
Article in aBIOTECH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 50 citations in OpenAlex.
- AI-designed OpenCRISPR-1 performs robust knockout, base editing, and prime editing in rice.The New phytologist · 2026Article
- Review
- CRISPR/Cas-mediated genome editing: playing a versatile role in mitigating the challenges of sustainable rice improvement.3 Biotech · 2025Review
- CRISPR-GATE: a one-stop repository and guide to computational resources for genome editing experimentation.Briefings in bioinformatics · 2025Review
- Genetic Databases and Gene Editing Tools for Enhancing Crop Resistance against Abiotic Stress.Biology · 2023Review
- Genome Editing and Improvement of Abiotic Stress Tolerance in Crop Plants.Life (Basel, Switzerland) · 2023Review
- Application of CRISPR/Cas system in cereal improvement for biotic and abiotic stress tolerance.Planta · 2022Review
- Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors.Communications biology · 2022Article
- Genome Engineering Technology for Durable Disease Resistance: Recent Progress and Future Outlooks for Sustainable Agriculture.Frontiers in plant science · 2022Review
- Base Editors for Citrus Gene Editing.Frontiers in genome editing · 2022Article
- Predictable NHEJ Insertion and Assessment of HDR Editing Strategies in Plants.Frontiers in genome editing · 2022Article
- Genome editing techniques in plants: a comprehensive review and future prospects toward zero hunger.GM crops & food · 2021Review
- The Elite Alleles of OsSPL4 Regulate Grain Size and Increase Grain Yield in Rice.Rice (New York, N.Y.) · 2021Article
- Expanding plant genome-editing scope by an engineered iSpyMacCas9 system that targets A-rich PAM sequences.Plant communications · 2021Article
- Efficiency, Specificity and Temperature Sensitivity of Cas9 and Cas12a RNPs for DNA-free Genome Editing in Plants.Frontiers in genome editing · 2021Article
- Establishment of an Efficient Protoplast Regeneration and Transfection Protocol for Field Cress (Frontiers in genome editing · 2021Article
- Article
- Applications of CRISPR/Cas to Improve Crop Disease Resistance: Beyond Inactivation of Susceptibility Factors.iScience · 2020Review
- ACBE, a new base editor for simultaneous C-to-T and A-to-G substitutions in mammalian systems.BMC biology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The CRISPR/Cas9-mediated base editing technology can efficiently generate point mutations in the genome without introducing a double-strand break (DSB) or supplying a DNA donor template for homology-directed repair (HDR). In this study, adenine base editors (ABEs) were used for rapid generation of precise point mutations in two distinct genes,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.